Get out of Paper
For clinical trial organizations to take advantage of any of the future technology innovations, they must first be entirely out of paper.
It is impossible to participate in the clinical trial of tomorrow – including virtual trials, remote monitoring, real-time data exchange, and real-world evidence – when a site is maintaining its records in either a paper file or a generic, disconnected, document management tool.
A majority of research sites have already made this shift, with 61% planning to be on an eRegulatory platform before the end of 2020. However, for the remainder, it is vital to future operations that a transition to eRegulatory be an essential element of your 2020 strategic roadmap.
As you explore your options, it’s vital you invest in a best-in-class eRegulatory vendor that will in turn, invest in you. Build your list of all required or must-have eReg features and think-through those features that are important to needs specific to your organization, so you are better prepared to evaluate potential eReg options. We built a eRegulatory capability checklist to help get you started.
Take the time to understand the nuances of your current workflows and processes to be able to explore eReg options that allow you to maximize those – instead of changing your operations to meet a platform’s limitations.